$VICR

Davies Philip D sold $195K of VICR

Davies Philip D (VP Global Sales & Marketing) sold 600 shares of VICOR CORP (VICR) at $325.18 ($0.20M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Davies Philip D
Published Jun 2, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 2:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

Because it’s a planned 10b5-1 sale and the disclosed amount is relatively small, it is more likely to be noise than a fundamental signal.

02

Market read

Primarily a compliance/ownership-change datapoint; limited expected impact on valuation or near-term fundamentals.

03

What to watch

Traders may want to compare this sale to prior Form 4 activity (frequency/size) to assess whether selling is accelerating or consistent.

Relevance 6/10Novelty 2/10Timing: Filed today; transaction occurred 2026-06-01.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by an officer/director under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp disclosed an officer/director open-market sale of 600 shares under a pre-arranged 10b5-1 plan, per SEC Form 4.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 open-market sale with an explicitly pre-arranged 10b5-1 plan, and the disclosed size is modest relative to typical liquidity for a public small/mid-cap.

Market effects

Minimal—single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale can still coincide with internal expectations of near-term risk, even if the plan is pre-arranged.

Key entities

  • VICOR CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • Davies Philip D

    VP Global Sales & Marketing; reported the sale of 600 shares.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: